文献速递类风湿关节炎

患者报告结局的跨中心变异低于类风湿关节炎客观活动度指标:一项横断面研究

Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

结果显示,患者报告结局(疼痛、HAQ、患者总体评估)归因于中心的变异低于客观指标(关节计数、ESR、医生总体评估),RAPID3的跨中心变异也低于DAS28v3。提示患者报告结局在不同中心间更具可比性,而客观指标需要标准化。

要点

  • 患者报告结局归因于中心的变异为1.53%–3.71%,低于客观指标的5.92%–9.25%。
  • RAPID3归因于中心的变异为2.6%,低于DAS28v3的11.75%。
  • 患者报告结局跨中心可比性更好,客观指标需标准化。

核心结论

  • 患者报告结局的跨中心变异低于类风湿关节炎客观活动度指标,提示前者在不同中心间更具可比性,而后者需要标准化。

主要发现

  • 在所有模型中,患者报告结局(疼痛、HAQ、患者总体评估)归因于招募中心的变异比例均低于客观指标(关节计数、ESR、医生总体评估)。
  • 全模型中,患者报告结局归因于中心的变异从患者总体评估的1.53%到HAQ的3.71%,客观指标从医生总体评估的5.92%到ESR的9.25%。
  • RAPID3归因于中心的变异为2.6%,低于DAS28v3的11.75%。

临床怎么用

  • 在跨中心比较或临床研究中,患者报告结局可能比客观指标更可比,解读客观指标时应考虑中心间差异并推动标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess intercentre variability in the ACR core set measures, DAS28 based on three variables (DAS28v3) and Routine Assessment of Patient Index Data 3 in a multinational study. METHODS: Seven thousand and twenty-three patients were recruited (84 centres; 30 countries) using a standard protocol in the Quantitative Standard Monitoring of Patients with RA study. Analysis of variance (ANOVA) and mixed-effect analysis of covariance models were used to model the relationship between study centre and different patient-reported and physician-reported RA activity measures. These models were built to adjust for the remaining ACR core set measure (for each ACR core set measure or each composite index), socio-demographics and medical characteristics. ANOVA and analysis of covariance models yielded similar results, and ANOVA tables were used to present variance attributable to recruiting centre. RESULTS: The proportion of variances attributable to recruiting centre was lower for patient reported outcomes (PROs: pain, HAQ, patient global) compared with objective measures (joint counts, ESR, physician global) in all models. In the full model, variance in PROs attributable to recruiting centre ranged from 1.53% for patient global to 3.71% for HAQ compared with objective measures that ranged from 5.92% for physician global to 9.25% for ESR; and was lower for Routine Assessment of Patient Index Data 3 (2.6%) compared with DAS28v3 (11.75%). CONCLUSION: Intercentre variability in PROs is lower than objective measures of RA activity demonstrating that PROs may be more comparable across centres, and the need for standardization of objective measures.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Khan NA, Spencer HJ, Nikiphorou E, et al. Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study. Rheumatology (Oxford). 2017. PMID: 28575509. doi:10.1093/rheumatology/kex076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。